Literature DB >> 33459579

Changes in central adipose tissue after switching to integrase inhibitors.

Paula Debroy1, Han Feng1, Hongyu Miao1, Jovana Milic, Guido Ligabue2, Stefano Draisci2, Giulia Besutti2, Federica Carli2, Marianna Menozzi2, Cristina Mussini2, Giovanni Guaraldi2, Jordan E Lake1.   

Abstract

Background: Treatment with integrase strand transfer inhibitors (INSTIs) has been associated with excess weight gain, however the long-term effect of INSTI-based regimens on adipose tissue (AT) compartments remains unknown.
Objectives: To evaluate the effect of switching to an INSTI on visceral (VAT) and subcutaneous (SAT) AT in virologically-suppressed adults with HIV.
Methods: We performed a retrospective observational cohort study of ART experienced adults referred to the metabolic Clinic of the University of Modena and Reggio Emilia who had ≥2 assessments of body composition by abdominal computed tomography. An interrupted time series model with mixed-effect model incorporated was used to calculate VAT and SAT change rate, adjusting for smoking status, use of alcohol, and physical activity.
Results: A total of 698 patients were included: 156 who switched to an INSTI-based regimen and 542 who did not. After switch to INSTI, mean SAT area increased approximately 3-fold (before 0.27 vs after 0.73 cm2/month; p = 0.011), and VAT area 7-fold (0.18 vs 1.30 cm2/month; p < 0.001).Conclusions: Among PLWH on ART, both SAT and VAT gain accelerated after switching to an INSTI-based regimen. The associations between INSTIs and central adiposity require further investigation.

Entities:  

Keywords:  INSTI; central adiposity; fat; weight

Mesh:

Substances:

Year:  2021        PMID: 33459579      PMCID: PMC8033629          DOI: 10.1080/25787489.2020.1848131

Source DB:  PubMed          Journal:  HIV Res Clin Pract        ISSN: 2578-7470


  21 in total

1.  Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.

Authors:  Carl Grunfeld; Michael Saag; Joseph Cofrancesco; Cora Elizabeth Lewis; Richard Kronmal; Steven Heymsfield; Phyllis C Tien; Peter Bacchetti; Michael Shlipak; Rebecca Scherzer
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

2.  Longitudinal changes in visceral and subcutaneous adipose tissue and metabolic syndrome: Results from the Multicultural Community Health Assessment Trial (M-CHAT).

Authors:  Andrew W Tu; Karin H Humphries; Scott A Lear
Journal:  Diabetes Metab Syndr       Date:  2017-07-08

3.  Effect of longitudinal changes in visceral fat area on incidence of metabolic risk factors: the Hitachi health study.

Authors:  Yumi Matsushita; Toru Nakagawa; Shuichiro Yamamoto; Yoshihiko Takahashi; Tetsuji Yokoyama; Tetsuya Mizoue; Mitsuhiko Noda
Journal:  Obesity (Silver Spring)       Date:  2013-05-29       Impact factor: 5.002

4.  Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.

Authors:  Jordan E Lake; David Wohl; Rebecca Scherzer; Carl Grunfeld; Phyllis C Tien; Stephen Sidney; Judith S Currier
Journal:  AIDS Care       Date:  2011-06-24

5.  Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.

Authors:  Charles Kouanfack; Mireille Mpoudi-Etame; Pierrette Omgba Bassega; Sabrina Eymard-Duvernay; Sandrine Leroy; Sylvie Boyer; Martine Peeters; Alexandra Calmy; Eric Delaporte
Journal:  N Engl J Med       Date:  2019-07-24       Impact factor: 91.245

6.  Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Authors:  Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

7.  Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.

Authors:  Carl Grunfeld; David Rimland; Cynthia L Gibert; William G Powderly; Stephen Sidney; Michael G Shlipak; Peter Bacchetti; Rebecca Scherzer; Steven Haffner; Steven B Heymsfield
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

8.  Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot.

Authors:  Paula Debroy; Myung Sim; Kristine M Erlandson; Julian Falutz; Carla M Prado; Todd T Brown; Giovanni Guaraldi; Jordan E Lake
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

9.  Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race.

Authors:  Priya Bhagwat; Ighovwerha Ofotokun; Grace A McComsey; Todd T Brown; Carlee Moser; Catherine A Sugar; Judith S Currier
Journal:  Open Forum Infect Dis       Date:  2018-11-16       Impact factor: 3.835

10.  Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.

Authors:  Anne Marie Kerchberger; Anandi N Sheth; Christine D Angert; C Christina Mehta; Nathan A Summers; Ighovwerha Ofotokun; Deborah Gustafson; Sheri D Weiser; Anjali Sharma; Adaora A Adimora; Audrey L French; Michael Augenbraun; Jennifer Cocohoba; Seble Kassaye; Hector Bolivar; Usha Govindarajulu; Deborah Konkle-Parker; Elizabeth T Golub; Cecile D Lahiri
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

View more
  2 in total

1.  Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era.

Authors:  Gabriel Spieler; Andrew O Westfall; Dustin M Long; Andrea Cherrington; Greer A Burkholder; Nicholas Funderburg; James L Raper; Edgar T Overton; Amanda L Willig
Journal:  AIDS       Date:  2022-08-10       Impact factor: 4.632

2.  Association of HIV-1 Infection and Antiretroviral Therapy With Type 2 Diabetes in the Hispanic Population of the Rio Grande Valley, Texas, USA.

Authors:  Juan Carlos Lopez-Alvarenga; Dora A Martinez; Alvaro Diaz-Badillo; Liza D Morales; Rector Arya; Christopher P Jenkinson; Joanne E Curran; Donna M Lehman; John Blangero; Ravindranath Duggirala; Srinivas Mummidi; Ruben D Martinez
Journal:  Front Med (Lausanne)       Date:  2021-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.